U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT06801457) titled 'Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke' on Jan. 21.
Brief Summary: The primary objective of this study is to determine the efficacy and safety of inhaled normobaric hyperoxia therapy (NBO) beginning in the pre-hospital setting in patients with suspected acute cerebral ischemia (ACI) due to large vessel occlusion presenting within 6 hours of symptom onset.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Stroke Acute
Intervention:
OTHER: NBO
NBO will be conducted with inhalation of 100% oxygen.
OTHER: Control
Best medical care
Recruitment Status: N...